Chinese Team Devises Dual-Action Molecule to Redirect Immune Memory Against Tumors
Muscat: Chinese scientists have developed a novel synthetic molecule that acts as an “intratumoral vaccine,” designed to overcome a key limitation of current immunotherapy by redirecting the body’s pre-existing immune